Yinan Lin Joins Dickinson Wright Silicon Valley Office
Want to get our alerts?
Click “Subscribe Now” to get attorney insights on the latest developments in a range of services and industries.
Dickinson Wright is pleased to announce that Yinan Lin, Ph.D., has joined the firm’s Silicon Valley office as Of Counsel.
Yinan advises life sciences companies on intellectual property strategy and transactions, with a particular focus on complex IP structuring, portfolio management, and strategic agreements. She works with pharmaceutical and biotechnology clients across the full innovation lifecycle—from early-stage research through clinical development, manufacturing, and commercialization—drawing on scientific fluency, patent expertise, and transactional insight. Her deal experience includes IP licensing and asset acquisitions, license terminations and program divestitures, mergers and business acquisitions, R&D collaborations, supply chain and distribution agreements, and other commercial agreements supporting business operations, financing, partnering, monetization, and broader strategic goals.
With advanced training in chemistry and biomedical sciences, Yinan brings a thoughtful approach to protecting innovation in the life sciences. She has developed and implemented IP strategies for a range of therapeutic programs, including small molecules, biologics, and gene therapies. Yinan received her B.S. from Fudan University, her Ph.D. from Akron University, and her J.D. from Georgetown University Law Center.
Yinan advises life sciences companies on intellectual property strategy and transactions, with a particular focus on complex IP structuring, portfolio management, and strategic agreements. She works with pharmaceutical and biotechnology clients across the full innovation lifecycle—from early-stage research through clinical development, manufacturing, and commercialization—drawing on scientific fluency, patent expertise, and transactional insight. Her deal experience includes IP licensing and asset acquisitions, license terminations and program divestitures, mergers and business acquisitions, R&D collaborations, supply chain and distribution agreements, and other commercial agreements supporting business operations, financing, partnering, monetization, and broader strategic goals.
With advanced training in chemistry and biomedical sciences, Yinan brings a thoughtful approach to protecting innovation in the life sciences. She has developed and implemented IP strategies for a range of therapeutic programs, including small molecules, biologics, and gene therapies. Yinan received her B.S. from Fudan University, her Ph.D. from Akron University, and her J.D. from Georgetown University Law Center.
Contacts
